Literature DB >> 16335860

Supra-oesophageal manifestations of gastro-oesophageal reflux disease.

Manuel Rodríguez-Téllez1.   

Abstract

The extra-oesophageal signs that are most commonly related to gastro-oesophageal reflux include chest pain, asthma, chronic cough, posterior laryngitis and dental erosions. It is characteristic to find in such patients a poor presence of symptoms and endoscopic and pH-metric findings that are common in typical reflux. The therapeutic response to antisecretory drugs has become the most cost-effective tool for the diagnosis and treatment of this condition. Both the evidence available and expert agreement in consensus conferences support the use of proton pump inhibitors with doubled standard doses for at least 12 weeks in most cases. While an acceptable response is achieved with this significant acid inhibition, there are still questions to be answered in these and other aspects, such as the true prevalence, path physiology and diagnosis of this condition. It is therefore necessary and increasingly useful to create multidisciplinary teams with the aim to improve and promote understanding and the care of patients suffering from these supra-oesophageal symptoms caused by gastro-oesophageal reflux.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16335860     DOI: 10.2165/00003495-200565001-00010

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  30 in total

1.  Evaluation of omeprazole in the treatment of reflux laryngitis: a prospective, placebo-controlled, randomized, double-blind study.

Authors:  J P Noordzij; A Khidr; B A Evans; E Desper; R K Mittal; J F Reibel; P A Levine
Journal:  Laryngoscope       Date:  2001-12       Impact factor: 3.325

2.  Pilot study of the oral omeprazole test for reflux laryngitis.

Authors:  D C Metz; M L Childs; C Ruiz; G S Weinstein
Journal:  Otolaryngol Head Neck Surg       Date:  1997-01       Impact factor: 3.497

3.  Chronic cough and gastro-oesophageal reflux: a double-blind placebo-controlled study with omeprazole.

Authors:  T O Kiljander; E R Salomaa; E K Hietanen; E O Terho
Journal:  Eur Respir J       Date:  2000-10       Impact factor: 16.671

4.  Systematic review of proton pump inhibitors for the acute treatment of reflux oesophagitis.

Authors:  S J Edwards; T Lind; L Lundell
Journal:  Aliment Pharmacol Ther       Date:  2001-11       Impact factor: 8.171

5.  Gastroesophageal reflux in asthmatics: A double-blind, placebo-controlled crossover study with omeprazole.

Authors:  T O Kiljander; E R Salomaa; E K Hietanen; E O Terho
Journal:  Chest       Date:  1999-11       Impact factor: 9.410

6.  Chronic cough. The spectrum and frequency of causes, key components of the diagnostic evaluation, and outcome of specific therapy.

Authors:  R S Irwin; F J Curley; C L French
Journal:  Am Rev Respir Dis       Date:  1990-03

Review 7.  Medical treatment for reflux oesophagitis does not consistently improve asthma control: a systematic review.

Authors:  J L Coughlan; P G Gibson; R L Henry
Journal:  Thorax       Date:  2001-03       Impact factor: 9.139

8.  Adult asthma and gastro-oesophageal reflux: the effects of omeprazole therapy on asthma.

Authors:  H Teichtahl; I J Kronborg; N D Yeomans; P Robinson
Journal:  Aust N Z J Med       Date:  1996-10

Review 9.  The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury.

Authors:  J A Koufman
Journal:  Laryngoscope       Date:  1991-04       Impact factor: 3.325

10.  Omeprazole improves peak expiratory flow rate and quality of life in asthmatics with gastroesophageal reflux.

Authors:  T R Levin; R M Sperling; K R McQuaid
Journal:  Am J Gastroenterol       Date:  1998-07       Impact factor: 10.864

View more
  1 in total

Review 1.  Extra-esophageal manifestations of GERD: who responds to GERD therapy?

Authors:  Rishi D Naik; Michael F Vaezi
Journal:  Curr Gastroenterol Rep       Date:  2013-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.